Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection
Chronic pelvic pain (CPP) is defined as pain in the pelvic organs and related structures of at least 6 months’ duration. The pathophysiology of CPP is uncertain, and its treatment presents challenges. Botulinum toxin A (BoNT-A), known for its antinociceptive, anti-inflammatory, and muscle relaxant a...
Main Authors: | Jia-Fong Jhang, Hann-Chorng Kuo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-06-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/7/6/2232 |
Similar Items
-
O’Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome
by: Yuh-Chen Kuo, et al.
Published: (2015-07-01) -
Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome
by: Cheng-Ling Lee, et al.
Published: (2015-10-01) -
Interstitial Cystitis: Chronic Pelvic Pain Syndrome
by: Fatih Atuğ, et al.
Published: (2005-01-01) -
The Evaluation and Management of Interstitial Cystitis/Bladder Pain Syndrome
by: Samantha Kraemer, et al.
Published: (2019-04-01) -
Therapeutic Efficacy of onabotulinumtoxinA Delivered Using Various Approaches in Sensory Bladder Disorder
by: Po-Yen Chen, et al.
Published: (2020-01-01)